Close

Professor Andrew Briggs

Professor in Health Economics

United Kingdom

Tel.
+44 (0)207 927 2348
Andrew is a Professor of Health Economics at the London School of Hygiene & Tropical Medicine and co-director of the Global Health ECOnomics (GHECO) Centre at the School. Previously, he held the William R Lindsay Chair in Health Economics at the University of Glasgow.

Andrew has expertise in all areas of health economic evaluation -- he has published over 300 articles in the peer-reviewed literature. He has particularly focused on statistical methods for cost-effectiveness analysis. This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials. He also has a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness.

Andrew took a leadership role as co-chair of the Joint Society for Medical Decision Making (SMDM) and International Society for PharmacoEconomics and Outcomes Research (ISPOR) Task Force on Modelling Methods. The Task Force, which was responsible for producing a set of seven papers covering all aspects of modelling methods applied to medical decision making and health technology assessment. He is also the author of two successful textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and another published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Global Health Economics Centre

Teaching

Together with Zia Sadique, Andrew is module organiser for C1-1501 Economic Evaluation, part of the MSc Public Health at the School. He also co-leads two continuing professional development short courses with Mark Sculpher from University of York: a Foundations course and an Advanced course in Decision Modelling for Health Economic Evaluation.

Selected Publications

Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data
O’Neill, S; BIDULKA, P; Lugo-Palacios, DG; CARROLL, O; Leiva-Escobar, I; Silverwood, R; BRIGGS, A; Adler, AI; Khunti, K; GRIEVE, R;
2025
Diabetologia
Long‐term outcomes following alternative second‐line oral glucose‐lowering treatments: Results from the real‐world progression in type 2 diabetes mellitus United Kingdom (<scp>RAPIDS</scp>‐<scp>UK</scp>) model
CARROLL, OU; BIDULKA, P; Basu, A; Adler, AI; O'NEILL, S; BRIGGS, AH; Lugo‐Palacios, DG; Khunti, K; GRIEVE, R;
2025
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics
Pricing combination products: not how but who?
Towse, A; BRIGGS, A; Steuten, L;
2025
The European journal of health economics
Barrett's Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial.
Old, O; Jankowski, J; Attwood, S; Stokes, C; Kendall, C; Rasdell, C; Zimmermann, A; Massa, MS; Love, S; Sanders, S; Deidda, M; BRIGGS, A; Hapeshi, J; Foy, C; Moayyedi, P; Barr, H; BOSS Trial Team,;
2025
Gastroenterology
Cost-Effectiveness Analysis of Daridorexant for the Pharmacological Treatment of Chronic Insomnia Disorder in Adults.
BRIGGS, AH; Chalet, F-X; Cooper, J; Graham, P; Palmer, S; Miller, P; Walker, A; Greenwood, B; Morin, CM;
2025
PharmacoEconomics - open
Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn).
Bahuguna, P; Baker, PA; BRIGGS, A; Gulliver, S; Hesselgreaves, H; Mehndiratta, A; RUIZ, F; Tyagi, K; Wu, O; Guzman, J; Grieve, E;
2025
BMJ evidence-based medicine
Development of the natural history component of an early economic model for primary sclerosing cholangitis.
Bowlus, C; Levy, C; Kowdley, KV; Kachru, N; Jeyakumar, S; Rodriguez-Guadarrama, Y; Smith, N; BRIGGS, A; Sculpher, M; Ollendorf, D;
2025
Orphanet journal of rare diseases
Search strategies for "Guidance on the economic evaluation of the health impacts of climate action"
FALCONER, J; BRIGGS, A; RUIZ, F; Cubi-Molla, P; Dasgupta, S; WHITMEE, S;
2025
London School of Hygiene & Tropical Medicine
Healthcare payor management practices are associated with health system performance and population health.
DORGAN, SJ; POWELL-JACKSON, T; BRIGGS, A;
2025
Social science & medicine (1982)
See more information